Form 8-K - Current report:
SEC Accession No. 0001104659-24-060715
Filing Date
2024-05-14
Accepted
2024-05-13 18:24:40
Documents
14
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414358d1_8k.htm   iXBRL 8-K 25847
2 EXHIBIT 99.1 tm2414358d1_ex99-1.htm EX-99.1 43665
  Complete submission text file 0001104659-24-060715.txt   253858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20240513.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20240513_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20240513_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2414358d1_8k_htm.xml XML 3652
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 24940754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)